RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:A Pectin-Based Delivery Nanoplatform with an Optimized Tradeoff between Active Targeting and Drug Loading for Hepatocellular Carcinoma Treatment.
A Pectin-Based Delivery Nanoplatform with an Optimized Tradeoff between Active Targeting and Drug Loading for Hepatocellular Carcinoma Treatment.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
天然多糖结构中的多价反应基团使其能够进行多样化修饰,从而构建具有整合功能的先进纳米药物以增强癌症治疗;因此,基于多糖的纳米平台在多功能性与最大化治疗效率之间实现优化权衡一直是长期的研究兴趣,然而这一领域仍相对未被充分探索。
我们在此报道了基于果胶的递送纳米平台,其在主动靶向与药物负载之间实现了优化权衡,用于肝细胞癌(HCC)的化学免疫治疗。具体而言,果胶的靶向部分半乳糖被部分氧化为醛基,通过氧化程度可同时调控主动靶向性能和药物偶联能力,从而获得三种不同氧化程度的果胶基聚合物前药OP2-DOX、OP6-DOX和OP10-DOX。随后筛选出OP6-DOX纳米前药(NPs)在平均流体力学尺寸、胶体稳定性、细胞摄取能力和体外细胞毒性特征方面为最优纳米平台。最重要的是,OP6-DOX NPs实现了86.8%的肿瘤抑制率(TIR),并在HCC组织中诱导肿瘤相关巨噬细胞(TAMs)从M2向M1的高效极化以及自然杀伤(NK)细胞的募集。
总体而言,本研究的结果可为基于多糖的纳米平台在癌症化学-固有免疫治疗中的主动靶向与药物负载权衡调控提供重要的理论指导。
The presence of multivalent reactive groups in the structure of natural polysaccharides enables diverse modifications toward advanced nanomedicines with integrated functionalities for enhanced cancer therapy; therefore, a polysaccharide-based nanoplatform with an optimized trade-off between multifunctionalities for a maximized therapeutic efficiency has been always a long-term research interest, which, however, remains relatively unexplored.
We report herein pectin-based delivery nanoplatforms with an optimized trade-off between active targeting and drug loading for chemo-immunotherapy of hepatocellular carcinoma (HCC). Specifically, the targeting moiety of pectin, galactose, is subjected to partial oxidization to an aldehyde function that enables the simultaneous modulation of active targeting properties and drug conjugation capacity by the degree of oxidation, affording pectin-based polymer prodrugs OP2-DOX, OP6-DOX, and OP10-DOX with three different degrees of oxidation.
OP6-DOX nanoprodrugs (NPs) are subsequently screened to be the optimal nanoplatform in terms of the mean hydrodynamic size, colloidal stability, cellular uptake capacity, and in vitro cytotoxicity profiles. Most importantly, OP6-DOX NPs achieve a tumor inhibition rate (TIR) of 86. 8%, which induces the efficient polarization of tumor-associated macrophages (TAMs) from M2 to M1 and natural killer (NK) cell recruitment in HCC tissues.
Overall, the outcomes of this study could serve as an important theoretical guidance on the active targeting and drug loading trade-off modulation of polysaccharide-based nanoplatforms for cancer chemo-innate immunotherapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。